Sale!
Adakveo®(crizanlizumab)

Adakveo®(crizanlizumab)

Original price was: $7.00.Current price is: $6.00.

Adakveo (crizanlizumab) is the first and only FDA-approved intravenous (IV) infusion used to lower the number of pain crises in people with sickle cell disease.

Category: Tags: , ,

Reviews

There are no reviews yet.

Be the first to review “Adakveo®(crizanlizumab)”

Your email address will not be published. Required fields are marked *

Related products